Assignee
UNIV TOULOUSE 3 PAUL SABATIER
FR·12 granted patents·19 pending applications·5 citations·filing 2004–2025
Top patents by PatentIndex Score
31 records- 0182US2025127136A1Novel method for promoting nodulation in plantsUNIV TOULOUSE 3 PAUL SABATIER·Filed 2024·Application pending·0 cites
- 0272US10583222B2Composite biomaterials with improved bioactivity and their use for bone substituteUNIV TOULOUSE 3 PAUL SABATIER·Filed 2016·Granted Mar 10, 2020·2 cites·11 claims
- 0371US2024301014A1Micropeptides and use of same for modulating gene expressionUNIV TOULOUSE 3 PAUL SABATIER·Filed 2024·Application pending·0 cites
- 0470US12185682B2Method for promoting nodulation in plantsUNIV TOULOUSE 3 PAUL SABATIER·Filed 2021·Granted Jan 7, 2025·0 cites·20 claims
- 0567US10195306B2Modified ceramics with improved bioactivity and their use for bone substituteUNIV TOULOUSE 3 PAUL SABATIER·Filed 2016·Granted Feb 5, 2019·1 cites·6 claims
- 0664US2024075097A1Therapeutic peptidesUNIV TOULOUSE 3 PAUL SABATIER·Filed 2022·Application pending·0 cites
- 0762US12024543B2Micropeptides and use of same for modulating gene expressionUNIV TOULOUSE 3 PAUL SABATIER·Filed 2019·Granted Jul 2, 2024·0 cites·6 claims
- 0856US2025134954A1Therapeutic peptidesUNIV TOULOUSE 3 PAUL SABATIER·Filed 2025·Application pending·0 cites
- 0954US2024294658A1Hybrid molecule comprising a fibrin-derived citrullinated peptide and an antibody or antibody fragment which binds to cd38 and/or cd138, and uses thereofUNIV TOULOUSE 3 PAUL SABATIER·Filed 2022·Application pending·0 cites
- 1054US2025197476A1Hybrid molecule comprising an antibody fc fragment and at least one fibrin-derived citrullinated peptide, and uses thereofUNIV TOULOUSE 3 PAUL SABATIER·Filed 2022·Application pending·0 cites
- 1153US2024307538A1Immune cell which has an fc receptor on its surface and to which is grafted a hybrid molecule comprising an antibody fc fragment and at least one fibrin-derived citrulline peptide, and uses thereofUNIV TOULOUSE 3 PAUL SABATIER·Filed 2022·Application pending·0 cites
- 1249US2016152794A1Electrically insulating composite material, method for producing such a material and use thereof as en electrical insulantUNIV TOULOUSE 3 PAUL SABATIER·Filed 2014·Application pending·0 cites
- 1348US11607443B2Therapeutic peptidesUNIV TOULOUSE 3 PAUL SABATIER·Filed 2017·Granted Mar 21, 2023·0 cites·9 claims
- 1447US2023119928A1Platelet lysate foam for cell culture, cell therapy and tissular regeneration and method for obatining sameUNIV TOULOUSE 3 PAUL SABATIER·Filed 2021·Application pending·0 cites
- 1547US2023125698A1Apheresis column for treating rheumatoid arthritisUNIV TOULOUSE 3 PAUL SABATIER·Filed 2021·Application pending·0 cites
- 1647US2022162547A1Treatment of respiratory diseases with a bacterium of the genus lactobacillusUNIV TOULOUSE 3 PAUL SABATIER·Filed 2020·Application pending·0 cites
- 1746US8017911B2Use of spinel ferrites as sensitive material for bolometric infrared detector devicesUNIV TOULOUSE 3 PAUL SABATIER·Filed 2004·Granted Sep 13, 2011·2 cites·17 claims
- 1846US2018318931A1Use of a deformable interface for the fabrication of complex partsUNIV TOULOUSE 3 PAUL SABATIER·Filed 2016·Application pending·0 cites
- 1944US2014255611A1Process for the anticorrosion treatment of a solid metal substrate and treated solid metal substrate capable of being obtained by such a processUNIV TOULOUSE 3 PAUL SABATIER·Filed 2012·Application pending·0 cites
- 2043US2011168957A1Electrically conductive solid composite material, and method of obtaining such a materialUNIV TOULOUSE 3 PAUL SABATIER·Filed 2009·Application pending·0 cites
- 2142US2024319115A1Method for generating a map representing mechanically altered areas of an adhesive within a bonded assembly of composite materials, corresponding device and computer programUNIV TOULOUSE 3 PAUL SABATIER·Filed 2022·Application pending·0 cites
- 2242US2020081009A1Inhibition of Chemokine CCL7 or Receptor CCR3 of Same for the Treatment and Diagnosis of Prostate CancerUNIV TOULOUSE 3 PAUL SABATIER·Filed 2019·Application pending·0 cites
- 2340US12023420B2Vascular stent with antithrombotic propertiesUNIV TOULOUSE 3 PAUL SABATIER·Filed 2019·Granted Jul 2, 2024·0 cites·15 claims
- 2440US2016251402A1Micropeptides and use of same for modulating gene expressionUNIV TOULOUSE 3 PAUL SABATIER·Filed 2016·Application pending·0 cites
- 2538US10401365B2Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancerUNIV TOULOUSE 3 PAUL SABATIER·Filed 2015·Granted Sep 3, 2019·0 cites·6 claims
- 2635US10563214B2Use of micropeptides for promoting plant growthUNIV TOULOUSE 3 PAUL SABATIER·Filed 2015·Granted Feb 18, 2020·0 cites·6 claims
- 2734US9637538B2Anti-HLA monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulinUNIV TOULOUSE 3 PAUL SABATIER·Filed 2013·Granted May 2, 2017·0 cites·5 claims
- 2834US2019135924A1Anti-hla monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulinUNIV TOULOUSE 3 PAUL SABATIER·Filed 2018·Application pending·0 cites
- 2932US10705076B2Anti-HLA monoclonal chimeric immunoglobulin, method and kit implementing such a monoclonal chimeric immunoglobulinUNIV TOULOUSE 3 PAUL SABATIER·Filed 2013·Granted Jul 7, 2020·0 cites·7 claims
- 3029US2019139844A1Method for processing an electrically insulating material providing same with self-adjusting electrical field grading properties for electrical componentsUNIV TOULOUSE 3 PAUL SABATIER·Filed 2017·Application pending·0 cites
- 3119US10501798B2Method and kit for prognosis of OPA1 gene induced diseases, E.G. Kjers optic atrophyUNIV TOULOUSE 3 PAUL SABATIER·Filed 2015·Granted Dec 10, 2019·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when UNIV TOULOUSE 3 PAUL SABATIER files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →